Abstract

Our recent studies of peptidylarginine deiminase 4 (PAD4) demonstrate that its non-catalytic Ca2+-binding sites play a crucial role in the assembly of the correct geometry of the enzyme. Here, we examined the folding mechanism of PAD4 and the role of Ca2+ ions in the folding pathway. Multiple mutations were introduced into the calcium-binding sites, and these mutants were termed the Ca1_site, Ca2_site, Ca3_site, Ca4_site and Ca5_site mutants. Our data indicate that during the unfolding process, the PAD4 dimer first dissociates into monomers, and the monomers then undergo a three-state denaturation process via an intermediate state formation. In addition, Ca2+ ions assist in stabilizing the folding intermediate, particularly through binding to the Ca3_site and Ca4_site to ensure the correct and active conformation of PAD4. The binding of calcium ions to the Ca1_site and Ca2_site is directly involved in the catalytic action of the enzyme. Finally, this study proposes a model for the folding of PAD4. The nascent polypeptide chains of PAD4 are first folded into monomeric intermediate states, then continue to fold into monomers, and ultimately assemble into a functional and dimeric PAD4 enzyme, and cellular Ca2+ ions may be the critical factor governing the interchange.

Highlights

  • PAD has various tissue distributions[14,15,16,17,18,19]

  • A case control study by a Japanese group revealed that the peptidylarginine deiminase 4 (PAD4) haplotype that is associated with susceptibility to rheumatoid arthritis (RA) increases production of deiminated peptides that act as autoantigens[27, 30]

  • We provided evidence that the binding of Ca2+ ions to the Ca3, Ca4- and Ca5-binding sites plays a crucial role in achieving the correct geometry for full activation of the enzyme[42]

Read more

Summary

Human Peptidylarginine Deiminase

Yi-Liang Liu[1,2], Chien-Yun Lee[1,3,4], Yu-Ni Huang[1], Hui-Yi Chen[5], Guang-Yaw Liu2 & Hui-Chih Hung[1,6,7]. Our recent studies of peptidylarginine deiminase 4 (PAD4) demonstrate that its non-catalytic Ca2+binding sites play a crucial role in the assembly of the correct geometry of the enzyme. The citrullination sites of these proteins have been identified; synthetic peptides derived from these proteins have been used to determine the sequence specificity of PAD protein substrates[24, 25]. Because PAD4 has histone methylarginine deiminase activity, the enzyme results in the negative regulation of downstream p53 target genes, including the p21 protein. The calcium-free, calcium-bound and substrate-bound PAD4 structures indicate that the binding of Ca2+ ions to the acidic concave enzyme surface induces a conformational change that creates the active site cleft[40]. Our recent studies of PAD4 demonstrate that the dimerization of the enzyme is essential for full enzymatic activity and calcium-binding cooperativity[41]. Based on biophysical data from several types of measurements, we propose that an intermediate state is formed during the folding process of PAD4 and that this intermediate is mainly stabilized by the binding of Ca2+ ions to the N-terminal Ca2+-binding site

Results and Discussion
Materials and Methods
Author Contributions
Additional Information
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call